Pfizer

27 aug. 2026, 23:02 UTC

Pfizer and BioNTech received FDA approval for their XFG-adapted COVID-19 vaccine, COMIRNATY XFG, boosting shares in after-market trading.

26 aug. 2026, 23:06 UTC

Pfizer Inc shares are lower in after-market hours amid notable volatility. Broader market weakness and a stronger U.S. Dollar Index contributed to the decline.

25 aug. 2026, 23:06 UTC

Pfizer Inc. shares are lower in after-market trading, reflecting weaker sentiment amid broader market declines linked to falling crude oil prices.

24 aug. 2026, 19:36 UTC

Pfizer Inc. shares are lower today, continuing a decline since Friday's close. The stock remains above its 20-day moving average.

21 aug. 2026, 23:01 UTC

Pfizer Inc shares are lower in after-market trading, reflecting a downward trend amid broader market volatility related to inflation and government debt concerns.

20 aug. 2026, 19:41 UTC

Pfizer Inc's shares are lower today amid a broader downturn in the Pharmaceuticals sub-sector, marking a shift from recent gains.

19 aug. 2026, 23:51 UTC

Pfizer Inc shares are lower in after-market hours, reversing gains from three consecutive sessions. No specific news was identified to explain the price action.

18 aug. 2026, 19:16 UTC

Pfizer reported second-quarter adjusted EPS of $0.77, exceeding estimates, and raised its sales outlook for fiscal year 2026, with shares trading higher.

17 aug. 2026, 23:36 UTC

Pfizer Inc shares are lower in after-market hours following the announcement of Xtandi's new indication for prostate cancer treatment. The broader market also declined.

14 aug. 2026, 23:51 UTC

Pfizer Inc. shares are higher in after-market hours amid broader economic concerns following a reported decline in U.S. retail sales for July.

13 aug. 2026, 23:16 UTC

Pfizer Inc shares are lower in after-market hours following a decline from earlier gains. No specific news was identified to explain the movement.

12 aug. 2026, 23:02 UTC

Pfizer shares rose after Chairman Albert Bourla bought 38,000 shares at $26.34, totaling about $1 million, signaling confidence in the company's prospects.

11 aug. 2026, 19:26 UTC

Pfizer Inc. shares are lower amid a $44 million settlement over its Chantix drug, which allegedly contained a cancer-linked substance.

10 aug. 2026, 23:01 UTC

Pfizer Inc. shares are lower in after-market hours, continuing a decline since Monday's close amid rising Treasury yields and inflation concerns.

8 aug. 2026, 00:02 UTC

Pfizer Inc shares are lower in after-market hours with no specific news identified. Broader market concerns about interest rate hikes continue to influence sentiment.

7 aug. 2026, 23:01 UTC

Pfizer Inc shares are lower in after-market hours, reaching a session low earlier. No specific news was identified to explain the decline.

6 aug. 2026, 23:51 UTC

Pfizer Inc shares are lower in after-market hours. The decline follows increased crude oil prices and a strengthening U.S. dollar, contributing to market volatility.

5 aug. 2026, 23:02 UTC

Pfizer Inc shares are modestly higher in after-market hours, reaching a session high before pulling back slightly. No specific news was identified for the movement.

4 aug. 2026, 23:21 UTC

Pfizer Inc shares are lower in after-market hours, with no specific news identified for the decline. Broader market sentiment remains positive amid falling crude oil prices.

3 aug. 2026, 23:46 UTC

Pfizer Inc shares are higher in after-market trading ahead of earnings. The stock remains above its 20-day moving average, reflecting positive market sentiment.

31 iul. 2026, 23:06 UTC

Pfizer Inc shares are higher in after-market hours, reflecting slight gains since Friday's close. The stock remains near the upper end of its one-month range.

30 iul. 2026, 23:26 UTC

Pfizer shares are higher in after-market trading following Phase 3 trial results for LITFULO in nonsegmental vitiligo, despite three prior sessions of lower closes.

29 iul. 2026, 23:16 UTC

Pfizer and BioNTech received European Commission approval for their XFG-adapted COVID-19 vaccine, valid across all EU member states. Shares are trading roughly flat after-market.

28 iul. 2026, 23:26 UTC

Pfizer Inc shares are lower in after-market hours, reversing an earlier gain. The stock remains above its 20-day moving average.

27 iul. 2026, 18:56 UTC

Pfizer Inc is trading higher, driven by gains in the Pharmaceuticals sub-sector. Shares pulled back earlier in the session from a session high.

24 iul. 2026, 18:06 UTC

Pfizer Inc. shares are lower today, reflecting broader market trends. Earlier, shares fell significantly before partially recovering amid declining crude oil prices.

23 iul. 2026, 09:41 UTC

Pfizer Inc. shares are higher in pre-market trading following FDA acceptance of a Priority Review for TALZENNA in combination with XTANDI for prostate cancer.

22 iul. 2026, 23:02 UTC

Pfizer Inc. shares are higher in after-market hours following the FDA's acceptance of a Priority Review for TALZENNA and XTANDI in prostate cancer treatment.

21 iul. 2026, 23:11 UTC

Pfizer Inc. options trading showed light volume, with calls outpacing puts and a put/call ratio of 0.56. Shares were little changed in after-market hours.

20 iul. 2026, 23:16 UTC

Pfizer Inc shares are higher in after-market trading, maintaining above their 20-day moving average despite broader market pressures from rising treasury yields.